Ophthalmology

Top Story

VIDEO: LADDER trial underway to compare long-term port delivery of ranibizumab with monthly injections

May 3, 2016

SEATTLE — At the Association for Research in Vision and Ophthalmology meeting, Jill Hopkins, MD, medical director at Genentech, describes the company's LADDER trial, an ongoing phase 2 trial whose purpose is to compare monthly intravitreal injections of ranibizumab in patients with wet age-related macular degeneration with long-term delivery of ranibizumab delivered via the company's port delivery system.

Meeting News CoverageVideo

VIDEO: Clinical trials show similarities between ranibizumab, aflibercept in treating DME

May 3, 2016
SEATTLE — At the Association for Research in Vision and Ophthalmology meeting, Marco A. Zarbin, MD, PhD, discusses a review of randomized clinical trials of anti-VEGF…
Meeting News Coverage

Abnormal ERGs reversed to normal in patients treated with Jetrea

May 3, 2016
SEATTLE — Full-field electroretinograms in patients treated with ocriplasmin changed normally, and treated patients with abnormal ERGs reversed to normal by 2…
Meeting News Coverage

CooperVision studies myopia control using daily disposables in children

May 3, 2016
SEATTLE – “With every diopter of increase in myopia, you have an increased risk of ocular pathology,” according to Arthur Back, BOptom, PhD
Meeting News Coverage

Lower levels of vitamin D associated with increased risk of noninfectious uveitis

May 3, 2016
SEATTLE — Patients with noninfectious uveitis had lower levels of vitamin D compared to patients without noninfectious uveitis, according to a poster presented…
More News Headlines »
Clinical Science

Forming a Consensus: Data and Guidance for Physicians Treating Diabetic Macular Edema

Ophthalmic Surgery, Lasers and Imaging Retina, April 2016, Volume 47 Issue 4
The diabetic macular edema (DME) treatment paradigm has evolved as the understanding of the disease pathology has…
More »
CME

Imaging Modalities in Clinical Trials

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology…
More »
Featured
Highlights from ARVO

Highlights from ARVO

Video
Meeting News Coverage

VIDEO: PlayStation effective for amblyopia treatment

May 3, 2016
More »